Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move: (TSXV: $META.V) (CSE: $EURO.C) (CSE: $HUGE.C) (CSE: $CURA.C) (CSE: $TIUM.C)
Delta, Kelowna, BC –August 21, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/08211META-EURO-HUGE-CURA-TIUM.asp
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few early announcements.
But first, in recent news, the federal government has become overwhelmed with the large amount of cannabis research applications that have been steadily coming in since last October.
As of last month, there were 251 applicants waiting in the queue for approval, and scientists are becoming increasingly irritated with the stagnancy of the process, which is currently subject to waits lasting months at a time.
“It’s incredibly slow—much slower than it used to be,” University of Lethbridge plant geneticist Igor Kovalchuk, told Science magazine. “October 17, 2018, is when things slowed down tremendously.”
Federal legalization produced an instant flood of cannabis research applications for Health Canada which they are attempting to manage on top of those applications for cultivation, processing, retail and other aspects of the strictly-regulated industry that require the federal agency’s approval.
Health Minister Ginette Petitpas-Taylor announced in May that it is investing in its own research projects relating to the drug.
“We are investing in research to provide the evidence needed to maintain policies for cannabis use that protect the health and safety of Canadians,” she said.
National Access Cannabis Corp. (TSXV: META), Canada's largest cannabis retailer1, today provided investors with a corporate and retail sales update. The Company is successfully executing on its growth strategy and has achieved over $50 million in retail sales since legalization, with cumulative gross margin in excess of 31%. The Company is targeting to have 40 operating stores by the end of calendar 2019.
"NAC is rapidly growing its store count and revenue," said Mark Goliger, CEO of NAC. "We have been granted 10 licenses in Alberta since the ending of the moratorium on May 31st, and we expect positive movement with our licence applications in British Columbia. We now have 30 stores open, with another 5 stores licensed and in development. We expect continued revenue momentum as we roll out improved and streamlined store designs to enhance customer experience. With the recent filing of our final base shelf prospectus to provide us with flexible access to capital, we are confident in our ability to execute on our strategic growth initiatives to continue our leadership position in Canadian cannabis retail."
The Company's current portfolio of 35 licensed locations is split as follows:
● 25 NewLeaf Cannabis™ stores in Alberta
● 9 Meta Cannabis Supply Co.™ stores in Manitoba
● 1 Meta Cannabis Supply Co.™ store in Saskatchewan
FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) today announced the launch of its online ordering system for the direct fulfillment of medicinal cannabis orders. Through its wholly-owned subsidiary, FV Pharma Inc., clients with a prescription from a medical practitioner or a registration number with Health Canada can now place an order online for dried cannabis on FVPharma.com.
"The launch of a functional online ordering portal to fulfill prescriptions for medicinal cannabis is a very important milestone for FSD Pharma. Since receipt of our Sale for Medical Purposes license earlier in June, we are now open for registration online to a wider client base and we are pleased that patients have already begun to use our user friendly website," said Raza Bokhari, MD, FSD Executive Co-Chairman & Chief Executive Officer.
"I want to personally congratulate the FSD Pharma team in helping the company advance into this important phase; we still have many more successful chapters to write together," concluded Dr. Bokhari.
EuroLife Brands Inc. (CSE: EURO) (OTCPK: CANVF), a leading global markets cannabis brand empowering the medical, recreational and CPG cannabis industry worldwide, announced that its corporate rebranding and repositioning within the cannabis industry has been completed with the launch of its EuroLifeBrands.com company website and corporate refocus.
"With our corporate rebrand complete, we are free to focus all efforts on continuing to grow the EuroLife cannabis brand across Europe and South America with a determination on new opportunities, strategic mergers and acquisitions to build shareholder value," said Shawn Moniz, Chief Executive Officer, EuroLife Brands Inc. "We expect to quickly become a leader in the burgeoning CPG CBD market across Europe by leveraging our rich repository of unbiased and physician-backed original educational content alongside our in-depth consumer data and analytics."
Demonstrating the Company's commitment to providing accessible cannabis education, its Director of Strategy and Education Daniel Davidzon was recently published in the National Post arguing for the crucial need for evidence-based cannabis education for cannabis consumers across Canada and the world. With so many cannabis-curious consumers confused over what treatments, products and services available to them, the need for an education-driven marketplace has grown exponentially and EuroLife is poised to lead the market with its repository of over 400 physician-backed and educator-approved articles and over 70 courses in its education platform.
The EuroLife executive team devoted a significant amount of time over the last quarter quantifying strategic partners across Europe in both the cannabis sector and other industries to determine the organization's realignment and strengthen the brand's presence across the continent. A recent report from the Brightfield Group, a leading market intelligence firm for the legal CBD and cannabis industries, estimated the European CBD market at USD $318 million in 2018, with the expectation of booming growth over 400 percent through 2023. The global CBD market is projected to grow from USD $1 billion in 2018 to USD $16 billion by 2026, according to Fior Market Research, a futuristic market intelligence company.
While the Company shifts its European and South American activities toward the CBD market, the anchor of its North American operations remains its Canadian and U.S.-focused digital cannabis education resource Cannvas.Me and Cannvas.Pet.
Eurolife is also announced the formation of a new Veterinary Advisory Board to guide educational content for its Canvas.Pet platform, as well as two new culinary-focused appointments to its Cannabis Sciences Advisory Board.
Award-winning veterinarian Dr. Scott Bainbridge has been appointed as the Veterinary Advisory Board lead, bringing with him nearly 20 years of veterinary expertise across a range of practices. Dr. Bainbridge and his team of eight vets diagnose approximately 15,000 cases every year at his Dundas West Animal Hospital (DWAH) in Toronto. Recently honoured by the Ontario Veterinary Medical Association with a lifetime achievement for public service, Dr. Bainbridge makes regular appearances on radio and television, appearing on CP24's Animal House Calls as a regular contributor and acts as the expert veterinarian for Canadian Living Magazine.
Award-winning author and culinary herbalist Pat Crocker, and founder of Upward Cannabis Kitchen, Carlton Bone, join the Cannabis Sciences Advisory Board to provide insights into evidence-based education around cannabis-infused edibles and beverages while contributing potential consumer packaged goods offerings to the EuroLife Marketplace platform.
A prolific author and in-demand speaker, Pat Crocker has written over 22 cookbooks. Her latest project is Healing Cannabis Edibles, a revolutionary cookbook and healing guide encouraging informed decisions around cannabis consumption to potentially improve certain health conditions. Ms. Crocker's books have sold hundreds of thousands of copies and have been featured on bestseller's lists across North America, including The Globe and Mail.
The founder of Portland, Oregon-based Upward Cannabis Kitchen, Carlton Bone has a passion for crafting high quality cannabis products and has developed a tea-based cannabis beverage line. Carlton also acts as the Chief Information Officer for Dr. Melanie Bone, a physician and educator with a focus on the intersection of cannabis and women's health care. Recently, the two collaborated on creating cannabis-infused suppositories to support anyone who needs relief due to chronic pain or additional comfort during their cycle.
Cansortium Inc. (CSE: TIUM-U) (OTCQB: CNTMF), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, announced today that it will begin trading today on the OTCQB Venture Market under the ticker "CNTMF". This is an upgrade from the Company's previous classification on the Pink Open Market.
Cansortium Chief Executive Officer Jose Hidalgo emphasized, "We are very pleased to begin trading on the OTCQB Venture Market less than five months after our initial public offering on the Canadian Securities Exchange, adding valuable visibility and additional liquidity for the benefit of our shareholders. We are intently focused on executing our growth strategy by expanding our cultivation capacity and dispensary platform in our home state of Florida and establishing our Fluent™ brand of cannabis products as a leader in each market where we choose to compete."
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States, today announced it has obtained eligibility with The Depository Trust Company ("DTC") for its shares listed on the OTCQX. DTC is a subsidiary of the Depository Trust & Clearing Corporation, a U.S. company that manages the electronic clearing and settlement of publicly traded companies. DTC eligibility provides cost benefits for investors and brokers trading in our securities in the United States.
"Receiving DTC eligibility will allow for a more friendly trading experience for our current and future shareholders," said Joseph Lusardi, CEO of Curaleaf. "Shareholders of Curaleaf will now be able to electronically transfer shares between brokerages in the U.S. and with this improved access to our shares, we expect a positive impact to the liquidity and demand for our stock."
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
